Janssen Pharmaceutical K.K. and Taiwan University Team Up to Fight Hepatitis B
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
Help employers find you! Check out all the jobs and post your resume.
by Richard Daverman, PhD
June 4, 2013 -- Janssen Pharma and the National Taiwan University Hospital will co-develop new drugs for hepatitis B. Janssen, the drug development subsidiary of Johnson & Johnson, will supply drug candidates to Pei-jer Chen, MD, a noted hepatitis B researcher at NTU College of Medicine. Dr. Chen will test how patients and the disease react to the compounds. The company expects to spend $7 million on the project in its first three years. More details....
Stock Symbol: (NYSE: JNJ)
Help employers find you! Check out all the jobs and post your resume.